Relationship between aging and dosage of warfarin: The current status of warfarin anticoagulant therapy for Japanese outpatients in a department of cardiovascular medicine

Journal of Cardiology

Volumn 53, Issue 3, 2009, Pages 355-360

  Miura, Takeshi ^a,b   Nishinaka, Toru ^a   Terada, Tomoyuki ^a   Yonezawa, Kazuya ^b  

^a OSAKA OHTANI UNIVERSITY   (Japan)

^b National Hospital Organization Hakodate Hospital   (Japan)

Author keywords

Aging; International normalized ratio; Japan; Japanese; PT INR; Warfarin

Indexed keywords

WARFARIN;

ADULT; AGED; AGING; ANTICOAGULANT THERAPY; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; EVENING DOSAGE; HUMAN; INTERNATIONAL NORMALIZED RATIO; JAPANESE; LONG TERM CARE; MAJOR CLINICAL STUDY; MORNING DOSAGE; OUTPATIENT CARE; PROTHROMBIN TIME;

ADULT; AGED; AGED, 80 AND OVER; AGING; ANTICOAGULANTS; ASIAN CONTINENTAL ANCESTRY GROUP; CARDIOLOGY SERVICE, HOSPITAL; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; INTERNATIONAL NORMALIZED RATIO; JAPAN; MALE; MIDDLE AGED; OUTPATIENTS; PROTHROMBIN TIME; RETROSPECTIVE STUDIES; WARFARIN;

EID: 67249112541     PISSN: 09145087     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jjcc.2008.12.003     Document Type: Article

References (18)

1. Wynne H., Cope L., Kelly P., Whittingham T., Edwards C., and Kamali F. The influence of age, liver and enantiomer concentrations on warfarin requirements. Br J Clin Pharmacol 40 (1995) 203-207
2. Gurwitz J.H., Avorn J., Ross-Degnan D., Choodnovskiy I., and Ansell J. Aging and the anticoagulant response to warfarin therapy. Ann Intern Med 116 (1992) 901-904
3. Redwood M., Taylor C., Bain J.B., and Matthews J.H. The association of age with dosage requirement for warfarin. Age Ageing 20 (1991) 217-220
4. Wickramasinghe L.S., Basu S.K., and Bansal S.K. Long-term oral anticoagulant therapy in elderly patients. Age Ageing 17 (1988) 388-396
5. Dobrzanski S., Duncan S.E., Harkiss A., and Wardlaw A. Age and weight as determinants of warfarin requirements. J Clin Hosp Pharm 8 (1983) 75-77
6. Jones B.R., Baran A., and Reidenberg M.M. Evaluating patients' warfarin requirements. J Am Geriatr Soc 28 (1980) 10-12
7. O'Malley K., Stevenson I.H., Ward C.A., Wood A.J., and Crooks J. Determinants of anticoagulant control in patients receiving warfarin. Br J Clin Pharmacol 4 (1977) 309-314
8. Eccles J.T. Control of warfarin therapy in the elderly. Age Ageing 4 (1975) 161-165
9. Honma H. Antithrombotic therapy in atrial fibrillation. Med Assoc Nippon Med Sch 1 (2005) 129-134
10. The Japanese Circulation Society. Guidelines for management of anticoagulant and antiplatelet therapy in cardiovascular disease. Circ J 68 Suppl. IV (2004) 1153-1219
11. Takahashi H., Kashima T., Kimura S., Murata N., Takaba T., Iwade K., Abe T., Tainaka H., Yasumori T., and Echizen H. Pharmacokinetic interaction between warfarin and a uricosuric agent, bucolome: application of in vitro approaches to predicting in vivo reduction of (S)-warfarin clearance. Drug Metab Disp 27 (1999) 1179-1186
12. Takahashi H., Wilkinson G.R., Nutescu E.A., Morita T., Ritchie M.D., Scordo M.G., Pengo V., Barban M., Padrini R., Ieiri I., Otsubo K., Kashima T., Kimura S., Kijima S., and Echizen H. Different contributions of polymorphisms in VKORC1 and CYP2C9 to intra- and inter-population differences in maintenance dose of warfarin in Japanese, Caucasians and African-Americans. Pharmacogenet Genomics 16 (2006) 101-110
13. Obayashi K., Nakamura K., Kawana J., Ogata H., Hanada K., Kurubayashi M., Hasegawa A., Yamamoto K., and Horiuchi R. VKORC1 gene variations are the major contributors of variation in warfarin dose in Japanese patients. Clin Pharmacol Ther 80 (2006) 169-178
14. The Japanese Circulation Society. Guidelines for pharmacotherapy of atrial fibrillation. Available at: http://www.j-circ.or.jp/guideline/pdf/JCS2006_ogawa_h.pdf; 2006 [accessed 18.01.08].
15. Crooks J., O'Malley K., and Stevenson I.H. Pharmacokinetics in the elderly. Clin Pharm 1 (1976) 280-296
16. Shepherd A.M.M., Hewick D.S., Moreland T.A., and Stevenson I.H. Age as a determinant of sensitivity to warfarin. Br J Clin Pharmacol 4 (1977) 315-320
17. Cushman M., Booth S.L., Possidente C.J., Davidson K.W., Sadowski J.A., and Bovill E.G. The association of vitamin K status with warfarin sensitivity at the onset of treatment. Br J Haematol 112 (2001) 572-577
18. Hazell K. Vitamin K deficiency in the elderly. Gerontol Clin (Basel) 12 (1970) 10-17